Dysbiosis in Parkinson's disease might be triggered by certain antibiotics

Area of Science:

• Neuroscience
• Microbiology
• Epidemiology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms resulting from neuronal loss.
• Gastrointestinal issues and bacterial dysbiosis are common in PD patients years before motor symptom onset.
• Gut microbiome alterations may precede and potentially contribute to PD pathogenesis.

Purpose of the Study:

• To investigate the hypothesis that antibiotic consumption contributes to gut dysbiosis in Parkinson's disease.
• To explore the role of antibiotics in promoting curli-producing Enterobacteria and subsequent amyloid propagation.
• To examine the correlation between antibiotic use and PD prevalence in European countries.

Main Methods:

• Comparative analysis of PD prevalence data and antibiotic consumption statistics across EU countries.
• Focus on the association between specific antibiotic classes (narrow-spectrum penicillin + penicillinase-resistant penicillin) and PD prevalence.
• Literature review on the role of bacterial amyloid curli and systemic inflammation in neurodegeneration.

Main Results:

• A significant positive correlation was observed between the consumption of narrow-spectrum penicillin and penicillinase-resistant penicillin and increased PD prevalence.
• Antibiotic use can induce systemic inflammation and gut microbiome dysbiosis.
• Curli, a bacterial amyloid, may play a role in the prion-like spread of alpha-synuclein pathology from the gut to the central nervous system.

Conclusions:

• Antibiotic consumption, specifically certain penicillins, is potentially linked to an increased prevalence of Parkinson's disease.
• Gut dysbiosis induced by antibiotics may facilitate the development and progression of PD.
• Further research is warranted to elucidate the precise mechanisms linking antibiotic exposure, gut microbiome, and Parkinson's disease.